Commercial Credit Report for Alpa Laboratories Limited

CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals. Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue. We also offer solutions that can help ease private company financial risk assessment. Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively.

A partial report preview for Alpa Laboratories Limited is shown below. Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database. To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

	Alpa Laboratories Limited
33/2 Pigdamber, A.B. Road, Rau
Phone: +91 7314294567p:+91 7314294567	INDORE, 453446 India	Ticker: ALPAALPA

Business Summary

Alpa Laboratories Limited is an India-based company, which is engaged in manufacturing and selling pharmaceutical finished dosage forms. The Company’s product range includes a wide variety of ethical, generic, and over the counter (OTC) drugs in various finished dosage forms for both human and veterinary use. Its human use products include capsules, such as Ampicillin Capsule IP/BP, Amoxycillin Trihydrate Capsule IP/BP, Cloxacillin Capsules IP/BP and Piroxicam Capsules IP BP; creams, gels and ointments, which include Lidocaine Hydrochloride Jelly IP/USP, Nitrofurazone Cream USP, Miconazole Cream IP/BP and Clobetasole Ointment/Cream BP; ear and eye drops, such as Benzylpenicillin Inj. IP/BP and Benzathine Penicillin Inj. IP/BP, and tablets, such as Ciprofloxacin Tablet IP / BP, Paracetamol Tablet IP/BP and Tinidazole Tablets IP/BP. Its veterinary products include boluses, such as Alpamin Bolus, Melovin-P Bolus and Alpazole Bolus, and injections, such as Atropine Inj. B.Vet.C and others.

Scores and Ratings

FRISK^® Score	Z'' Score	PAYCE^® Score	DBT Index	Moody's Rating	Fitch Rating	DBRS Rating
Yes	Yes	-	-	-	-	-

Financials, News and Filings

Latest Statement	Last Audit	News	SEC Filings	Bankruptcy Filings	Suit & Judgment Filings	Tax Lien Filings
12/31/2023	3/31/2023	Yes	-	-	-	-

Industries

SIC Code	Description
2834	Pharmaceutical preparations

Officers and Directors

Title	Name	Age	Title Date	Start Date
Chairman of the Board	Purushottam R.Patel	80	5/28/2016	3/25/1988
Chief Executive Officer	Jayesh P.Patel
Chief Financial Officer	Bakulesh C.Shah		7/17/2014
10 additional Officers and Directors records available in full report.

Business Names

Business Name
532878
ALPA
Alpa Laboratories Limited
Alpa Laboratories Ltd.

General Information

Number of Employees:	318	(As of 3/31/2023)
Outstanding Shares:	21,040,600	(As of 9/30/2023)
Shareholders:	11,984
Stock Exchange:	NSE
Fax Number:	+91 7314294444

SITE MAP | ABOUT US | DIRECTORY | STOCK QUOTE: CRMZ | SIGN IN